The European Commission has approved Otsuka's Dawnzera for the prevention of recurrent attacks in rare disease hereditary ...

CSL Ltd ( ASX: CSL) shares are trading around $177, a long way below their 52-week peak of $282.20. For a biotech that has ...

UiPath Chief Marketing Officer Michael Atalla argues that enterprises aren’t moving toward agent-only automation, but toward ...

This biotech giant could have major upside potential in 2026. The post A once-in-a-decade opportunity to buy CSL shares?

The Graft Versus Host Disease (GvHD) market across the seven major markets (7MM) is anticipated to witness substantial ...

A nearly 30-year study shows a strong long-term association between very high lipoprotein(a) levels and cardiovascular ...

Anemia and transfusion of red blood cells are common in patients undergoing valve surgery for infective endocarditis, and transfusion is linked to an increased risk for short- and long-term mortality.

CSL Ltd (ASX: CSL) shares slumped in 2025, but the outlook may be improving. Here’s why I think CSL could beat the ASX 200 ...

INDEPENDENCE, Mo. — The Community Services League (CSL) met with volunteers Sunday afternoon to set up its annual free Christmas store. CSL’s Christmas Store opens to pre-registered families on Monday ...

Australia’s largest drugmaker CSL Ltd. is committing roughly $1.5 billion to expand its US manufacturing footprint, joining a wave of pharmaceutical giants doubling down on American production. The ...

SYDNEY (Reuters) -Australian biotech CSL has cut its profit outlook and delayed plans to spin off its vaccine division, blaming an unprecedented fall in U.S. flu immunisation rates, which knocked its ...

(RTTNews) - CSL Behring Canada Inc., a unit of CSL Ltd. (CMXHF.PK), Monday announced that it has signed a Letter of Intent (LOI) with the pan-Canadian Pharmaceutical Alliance (pCPA) for the public ...